Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
10.18632/oncotarget.1596
Saved in:
Main Authors: | , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Impact Journals LLC
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/175000 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-175000 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1750002024-11-12T22:45:30Z Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model Siveen, K.S Mustafa, N Li, F Kannaiyan, R Ahn, K.S Kumar, A.P Chng, W.-J Sethi, G PHARMACOLOGY MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE bortezomib caspase 3 chemokine receptor CXCR4 cyclooxygenase 2 doxorubicin gelatinase B immunoglobulin enhancer binding protein interleukin 6 Ki 67 antigen melphalan nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase protein bcl 2 syndecan 1 thymoquinone transcription factor RelA tumor necrosis factor alpha vasculotropin antineoplastic agent benzoquinone derivative boronic acid derivative bortezomib immunoglobulin enhancer binding protein pyrazine derivative thymoquinone animal experiment animal model animal tissue antineoplastic activity antiproliferative activity apoptosis article Bcl 2 gene cancer cell culture cancer inhibition cancer resistance cell isolation concentration response controlled study cox2 gene CXCR4 gene drug potentiation drug sensitivity enzyme activation gene disruption gene product human human cell IL 6 gene in vitro study in vivo study ki 67 gene male migration inhibition MMP9 gene mouse multiple myeloma myeloma cell nonhuman p65 gene protein cleavage protein expression TNFalpha gene tumor invasion tumor xenograft VEGF gene animal Bagg albino mouse cell proliferation disease model drug effects drug potentiation drug screening genetics metabolism multiple myeloma nude mouse pathology randomization signal transduction tumor cell line Animals Antineoplastic Combined Chemotherapy Protocols Apoptosis Benzoquinones Boronic Acids Cell Line, Tumor Cell Proliferation Disease Models, Animal Drug Synergism Humans Male Mice Mice, Inbred BALB C Mice, Nude Multiple Myeloma NF-kappa B Pyrazines Random Allocation Signal Transduction Xenograft Model Antitumor Assays 10.18632/oncotarget.1596 Oncotarget 5 3 634-648 2020-09-09T02:58:12Z 2020-09-09T02:58:12Z 2014 Article Siveen, K.S, Mustafa, N, Li, F, Kannaiyan, R, Ahn, K.S, Kumar, A.P, Chng, W.-J, Sethi, G (2014). Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model. Oncotarget 5 (3) : 634-648. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.1596 19492553 https://scholarbank.nus.edu.sg/handle/10635/175000 Impact Journals LLC Unpaywall 20200831 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
bortezomib caspase 3 chemokine receptor CXCR4 cyclooxygenase 2 doxorubicin gelatinase B immunoglobulin enhancer binding protein interleukin 6 Ki 67 antigen melphalan nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase protein bcl 2 syndecan 1 thymoquinone transcription factor RelA tumor necrosis factor alpha vasculotropin antineoplastic agent benzoquinone derivative boronic acid derivative bortezomib immunoglobulin enhancer binding protein pyrazine derivative thymoquinone animal experiment animal model animal tissue antineoplastic activity antiproliferative activity apoptosis article Bcl 2 gene cancer cell culture cancer inhibition cancer resistance cell isolation concentration response controlled study cox2 gene CXCR4 gene drug potentiation drug sensitivity enzyme activation gene disruption gene product human human cell IL 6 gene in vitro study in vivo study ki 67 gene male migration inhibition MMP9 gene mouse multiple myeloma myeloma cell nonhuman p65 gene protein cleavage protein expression TNFalpha gene tumor invasion tumor xenograft VEGF gene animal Bagg albino mouse cell proliferation disease model drug effects drug potentiation drug screening genetics metabolism multiple myeloma nude mouse pathology randomization signal transduction tumor cell line Animals Antineoplastic Combined Chemotherapy Protocols Apoptosis Benzoquinones Boronic Acids Cell Line, Tumor Cell Proliferation Disease Models, Animal Drug Synergism Humans Male Mice Mice, Inbred BALB C Mice, Nude Multiple Myeloma NF-kappa B Pyrazines Random Allocation Signal Transduction Xenograft Model Antitumor Assays |
spellingShingle |
bortezomib caspase 3 chemokine receptor CXCR4 cyclooxygenase 2 doxorubicin gelatinase B immunoglobulin enhancer binding protein interleukin 6 Ki 67 antigen melphalan nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase protein bcl 2 syndecan 1 thymoquinone transcription factor RelA tumor necrosis factor alpha vasculotropin antineoplastic agent benzoquinone derivative boronic acid derivative bortezomib immunoglobulin enhancer binding protein pyrazine derivative thymoquinone animal experiment animal model animal tissue antineoplastic activity antiproliferative activity apoptosis article Bcl 2 gene cancer cell culture cancer inhibition cancer resistance cell isolation concentration response controlled study cox2 gene CXCR4 gene drug potentiation drug sensitivity enzyme activation gene disruption gene product human human cell IL 6 gene in vitro study in vivo study ki 67 gene male migration inhibition MMP9 gene mouse multiple myeloma myeloma cell nonhuman p65 gene protein cleavage protein expression TNFalpha gene tumor invasion tumor xenograft VEGF gene animal Bagg albino mouse cell proliferation disease model drug effects drug potentiation drug screening genetics metabolism multiple myeloma nude mouse pathology randomization signal transduction tumor cell line Animals Antineoplastic Combined Chemotherapy Protocols Apoptosis Benzoquinones Boronic Acids Cell Line, Tumor Cell Proliferation Disease Models, Animal Drug Synergism Humans Male Mice Mice, Inbred BALB C Mice, Nude Multiple Myeloma NF-kappa B Pyrazines Random Allocation Signal Transduction Xenograft Model Antitumor Assays Siveen, K.S Mustafa, N Li, F Kannaiyan, R Ahn, K.S Kumar, A.P Chng, W.-J Sethi, G Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model |
description |
10.18632/oncotarget.1596 |
author2 |
PHARMACOLOGY |
author_facet |
PHARMACOLOGY Siveen, K.S Mustafa, N Li, F Kannaiyan, R Ahn, K.S Kumar, A.P Chng, W.-J Sethi, G |
format |
Article |
author |
Siveen, K.S Mustafa, N Li, F Kannaiyan, R Ahn, K.S Kumar, A.P Chng, W.-J Sethi, G |
author_sort |
Siveen, K.S |
title |
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model |
title_short |
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model |
title_full |
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model |
title_fullStr |
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model |
title_full_unstemmed |
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model |
title_sort |
thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of nf-?b regulated gene products in multiple myeloma xenograft mouse model |
publisher |
Impact Journals LLC |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/175000 |
_version_ |
1821218164895121408 |